Form 4: Agilent Technologies Senior Vice President Acquires Shares and Options

Sentiment:

SEC Form 4 Filing


Bret DiMarco, a Senior Vice President at Agilent Technologies, acquired shares and options in the company on July 2, 2024, according to a Form 4 filing with the SEC.

Summary

  • On July 2, 2024, Bret DiMarco, a Senior Vice President at Agilent Technologies, acquired 1,618 shares of common stock at a price of $125.78 per share.
  • DiMarco also acquired options to purchase 4,595 shares of Agilent Technologies common stock at an exercise price of $125.78.
  • The stock options vest in four equal annual installments beginning on July 2, 2025, and expire on July 2, 2034.
  • The restricted stock units vest in four equal annual installments beginning on July 2, 2025 and are subject to a 1-year post-vest holding period.
  • Following the transaction, DiMarco directly owns 1,618 shares of Agilent Technologies common stock and options to purchase 4,595 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, which can be interpreted as a sign of confidence, but it doesn't provide enough information to strongly lean positive or negative.

Positives

  • The acquisition of shares and options by a senior executive could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's value and future performance.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
  • The vesting schedule of four equal annual installments is a common practice in the industry.
  • Companies like Thermo Fisher Scientific and Danaher also use similar equity-based compensation plans for their executives.

Key Dates

DateDescription
07/02/2024Date of transaction: acquisition of common stock and stock options.
07/02/2025First vesting date for the stock options and restricted stock units.
07/02/2034Expiration date for the stock options.
07/03/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.